Literature DB >> 15480419

PPARdelta status and Apc-mediated tumourigenesis in the mouse intestine.

Karen R Reed1, Owen J Sansom, Anthony J Hayes, Andreas J Gescher, Douglas J Winton, Jeffrey M Peters, Alan R Clarke.   

Abstract

Based on recent reports that peroxisome proliferator-activated receptor delta (PPARdelta) activation promotes tumourigenesis, we have investigated the role of this protein in Apc-mediated intestinal tumourigenesis. We demonstrate that the inactivation of Apc in the adult small intestine, while causing the expected nuclear accumulation of beta-catenin, does not cause the expected increase in PPARdelta mRNA or protein but conversely, the levels of PPARdelta mRNA and protein are lowered. Furthermore, we find that ApcMinPPARdelta-null mice exhibit an increased predisposition to intestinal tumourigenesis. Our data suggest that PPARdelta is not directly regulated by beta-catenin, and that inhibition of PPARdelta activity is unlikely to be an appropriate strategy for the chemoprevention or chemotherapy of intestinal malignancies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15480419     DOI: 10.1038/sj.onc.1208143

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  45 in total

1.  PPARδ Mediates the Effect of Dietary Fat in Promoting Colorectal Cancer Metastasis.

Authors:  Dingzhi Wang; Lingchen Fu; Jie Wei; Ying Xiong; Raymond N DuBois
Journal:  Cancer Res       Date:  2019-06-25       Impact factor: 12.701

Review 2.  The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention.

Authors:  Jeffrey M Peters; Yatrik M Shah; Frank J Gonzalez
Journal:  Nat Rev Cancer       Date:  2012-02-09       Impact factor: 60.716

3.  Immunomodulatory action of dietary fish oil and targeted deletion of intestinal epithelial cell PPARδ in inflammation-induced colon carcinogenesis.

Authors:  Jennifer M Monk; Wooki Kim; Evelyn Callaway; Harmony F Turk; Jennifer E Foreman; Jeffrey M Peters; Weimin He; Brad Weeks; Robert C Alaniz; David N McMurray; Robert S Chapkin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-09-22       Impact factor: 4.052

4.  Molecular Pathways: Dietary Regulation of Stemness and Tumor Initiation by the PPAR-δ Pathway.

Authors:  Semir Beyaz; Ömer H Yilmaz
Journal:  Clin Cancer Res       Date:  2016-10-04       Impact factor: 12.531

5.  Crosstalk between peroxisome proliferator-activated receptor delta and VEGF stimulates cancer progression.

Authors:  Dingzhi Wang; Haibin Wang; Yong Guo; Wei Ning; Sharada Katkuri; Walter Wahli; Beatrice Desvergne; Sudhansu K Dey; Raymond N DuBois
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-05       Impact factor: 11.205

6.  Modulation of gastrointestinal inflammation and colorectal tumorigenesis by peroxisome proliferator-activated receptor-β/δ (PPARβ/δ).

Authors:  Jeffrey M Peters; Jose L Morales; Frank J Gonzalez
Journal:  Drug Discov Today Dis Mech       Date:  2011-11-29

7.  Transcription factor AP1 binds the functional region of the promoter and regulates gene expression of human PPARdelta in LoVo cell.

Authors:  Xiaogang Jiang; Xudong Yang; Yan Han; Shemin Lu
Journal:  Tumour Biol       Date:  2013-07-06

8.  The Role of Peroxisome Proliferator-Activated Receptor beta/delta on the Inflammatory Basis of Metabolic Disease.

Authors:  Teresa Coll; Emma Barroso; David Alvarez-Guardia; Lucía Serrano; Laia Salvadó; Manuel Merlos; Xavier Palomer; Manuel Vázquez-Carrera
Journal:  PPAR Res       Date:  2010-07-27       Impact factor: 4.964

9.  PPARδ promotes oncogenic redirection of TGF-β1 signaling through the activation of the ABCA1-Cav1 pathway.

Authors:  Nam-Gu Her; Seong-In Jeong; Kyucheol Cho; Tae-Kyu Ha; Jikhyon Han; Kyung-Phil Ko; Soon-Ki Park; Jin-Hee Lee; Min-Goo Lee; Byung-Kyu Ryu; Sung-Gil Chi
Journal:  Cell Cycle       Date:  2013-04-17       Impact factor: 4.534

10.  Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) attenuates carbon tetrachloride hepatotoxicity by downregulating proinflammatory gene expression.

Authors:  Weiwei Shan; Prajakta S Palkar; Iain A Murray; Emily I McDevitt; Mary J Kennett; Boo Hyon Kang; Harriet C Isom; Gary H Perdew; Frank J Gonzalez; Jeffrey M Peters
Journal:  Toxicol Sci       Date:  2008-07-12       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.